Previous close | 79.32 |
Open | 79.55 |
Bid | 79.13 x 800 |
Ask | 79.64 x 1200 |
Day's range | 78.71 - 79.99 |
52-week range | 64.41 - 83.25 |
Volume | |
Avg. volume | 11,210,260 |
Market cap | 99.959B |
Beta (5Y monthly) | 0.50 |
PE ratio (TTM) | 12.28 |
EPS (TTM) | 6.47 |
Earnings date | 01 May 2024 - 06 May 2024 |
Forward dividend & yield | 2.66 (3.35%) |
Ex-dividend date | 19 Apr 2024 |
1y target est | 87.85 |
CVS Health (CVS) concluded the recent trading session at $79.43, signifying a +0.14% move from its prior day's close.
CVS Health® (NYSE: CVS) today announced more than $3 million in new grants to support organizations in Phoenix working to increase equitable access to health care, address social determinants of health and educate the community on the effects of air pollution. This announcement was made during a Project Health event in Phoenix and included CVS Health leaders, community organizations and local officials.
PBMs have used various strategies over the years to squeeze independent pharmacies, and these tactics are on the rise as the federal government takes aim at reigning in the notorious middlemen.